130 related articles for article (PubMed ID: 15202737)
21. Excessive follicular response to controlled ovarian stimulation in a woman with menopausal FSH levels: case report.
Tozer AJ; Al-Shawaf T; Gillott CM; Lower AM; Grudzinskas JG
Hum Reprod; 2004 Jan; 19(1):107-9. PubMed ID: 14688166
[TBL] [Abstract][Full Text] [Related]
22. Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial.
Andersen AN; Devroey P; Arce JC
Hum Reprod; 2006 Dec; 21(12):3217-27. PubMed ID: 16873892
[TBL] [Abstract][Full Text] [Related]
23. Impact of luteal phase support on pregnancy rates in intrauterine insemination cycles: a prospective randomized study.
Erdem A; Erdem M; Atmaca S; Guler I
Fertil Steril; 2009 Jun; 91(6):2508-13. PubMed ID: 18692788
[TBL] [Abstract][Full Text] [Related]
24. Highly purified FSH is as efficacious as recombinant FSH for ovulation induction in women with WHO Group II anovulatory infertility: a randomized controlled non-inferiority trial.
Balen A; Platteau P; Andersen AN; Devroey P; Helmgaard L; Arce JC;
Hum Reprod; 2007 Jul; 22(7):1816-23. PubMed ID: 17449511
[TBL] [Abstract][Full Text] [Related]
25. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
Hohmann FP; Macklon NS; Fauser BC
J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
[TBL] [Abstract][Full Text] [Related]
26. Recombinant versus highly-purified, urinary follicle-stimulating hormone (r-FSH vs. HP-uFSH) in ovulation induction: a prospective, randomized study with cost-minimization analysis.
Revelli A; Poso F; Gennarelli G; Moffa F; Grassi G; Massobrio M
Reprod Biol Endocrinol; 2006 Jul; 4():38. PubMed ID: 16848893
[TBL] [Abstract][Full Text] [Related]
27. Cumulative pregnancy rates in couples with anovulatory infertility compared with unexplained infertility in an ovulation induction programme.
Tadokoro N; Vollenhoven B; Clark S; Baker G; Kovacs G; Burger H; Healy D
Hum Reprod; 1997 Sep; 12(9):1939-44. PubMed ID: 9363711
[TBL] [Abstract][Full Text] [Related]
28. Suppression of LH during ovarian stimulation: effects differ in cycles stimulated with purified urinary FSH and recombinant FSH.
Fleming R; Rehka P; Deshpande N; Jamieson ME; Yates RW; Lyall H
Hum Reprod; 2000 Jul; 15(7):1440-5. PubMed ID: 10875848
[TBL] [Abstract][Full Text] [Related]
29. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
Vuong TN; Phung HT; Ho MT
Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
[TBL] [Abstract][Full Text] [Related]
30. Recovery of corpus luteum function after prolonged deprivation from gonadotrophin stimulation.
Weissman A; Loumaye E; Shoham Z
Hum Reprod; 1996 May; 11(5):943-9. PubMed ID: 8671368
[TBL] [Abstract][Full Text] [Related]
31. [From gene to disease; galactosemia and galactose-1-phosphate uridyltransferase deficiency].
Bosch AM; Waterham HR; Bakker HD
Ned Tijdschr Geneeskd; 2004 Jan; 148(2):80-1. PubMed ID: 14753129
[TBL] [Abstract][Full Text] [Related]
32. Ovulation induction with urinary follicle stimulating hormone versus human menopausal gonadotropin for clomiphene-resistant polycystic ovary syndrome.
Hughes E; Collins J; Vandekerckhove P
Cochrane Database Syst Rev; 2000; 1996(2):CD000087. PubMed ID: 10796690
[TBL] [Abstract][Full Text] [Related]
33. Pure FSH for ovulation induction in patients with polycystic ovary syndrome and resistant to clomiphene citrate therapy.
Neyro JL; Barrenetxea G; Montoya F; Rodriguez-Escudero FJ
Hum Reprod; 1991 Feb; 6(2):218-21. PubMed ID: 1905311
[TBL] [Abstract][Full Text] [Related]
34. Induction of follicular growth and production of a normal hormonal milieu in spite of using a constant low dose of luteinizing hormone in women with hypogonadotrophic hypogonadism.
Shoham Z; Howles CM; Zalel Y; Weissman A; Insler V
Hum Reprod; 1994 Mar; 9(3):431-6. PubMed ID: 7516348
[TBL] [Abstract][Full Text] [Related]
35. Highly purified hMG versus recombinant FSH plus recombinant LH in intrauterine insemination cycles in women ≥35 years: a RCT.
Moro F; Scarinci E; Palla C; Romani F; Familiari A; Tropea A; Leoncini E; Lanzone A; Apa R
Hum Reprod; 2015 Jan; 30(1):179-85. PubMed ID: 25398971
[TBL] [Abstract][Full Text] [Related]
36. Hypergonadotropic hypogonadism in female patients with galactosemia.
Kaufman FR; Kogut MD; Donnell GN; Goebelsmann U; March C; Koch R
N Engl J Med; 1981 Apr; 304(17):994-8. PubMed ID: 6782485
[TBL] [Abstract][Full Text] [Related]
37. IVF/ICSI outcome and serum LH concentration on day 1 of ovarian stimulation with recombinant FSH under pituitary suppression.
Bjercke S; Fedorcsak P; Abyholm T; Storeng R; Ertzeid G; Oldereid N; Omland A; Tanbo T
Hum Reprod; 2005 Sep; 20(9):2441-7. PubMed ID: 15919773
[TBL] [Abstract][Full Text] [Related]
38. Gonadotrophins for ovulation induction in women with polycystic ovarian syndrome.
Weiss NS; Nahuis M; Bayram N; Mol BW; Van der Veen F; van Wely M
Cochrane Database Syst Rev; 2015 Sep; (9):CD010290. PubMed ID: 26350625
[TBL] [Abstract][Full Text] [Related]
39. Ovarian luteinizing hormone priming preceding follicle-stimulating hormone stimulation: clinical and endocrine effects in women with long-term hypogonadotropic hypogonadism.
Balasch J; Fábregues F; Carmona F; Casamitjana R; Tena-Sempere M
J Clin Endocrinol Metab; 2009 Jul; 94(7):2367-73. PubMed ID: 19366842
[TBL] [Abstract][Full Text] [Related]
40. Recombinant follicle stimulating hormone is effective in poor responders to highly purified follicle stimulating hormone.
De Placido G; Alviggi C; Mollo A; Strina I; Varricchio MT; Molis M
Hum Reprod; 2000 Jan; 15(1):17-20. PubMed ID: 10611181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
